Back to top

Oric Pharmaceuticals initiates Himalayas-1 trial

Oric Pharmaceuticals (ORIC) announced the initiation of the Himalayas-1 global Phase 3 registrational trial in patients with metastatic castration-...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Bayer Aktiengesellschaft (BAYRY)

Oric Pharmaceuticals, Inc. (ORIC)